-
Vaccines, Blood & Biologics
-
Resources for You
-
-
FluMist
Proper Name: Influenza Vaccine Live, Intranasal
Tradename: FluMist
Manufacturer: MedImmune, LLC, License #1799
Indications:
- For the active immunization of individuals 2-49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
-
Supporting Documents
- July 17, 2009 Approval Letter - FluMist Label Revisions
2009/2010 Season Formulation - July 17, 2009 Approval Letter - FluMist 2009/2010 Formulation
2009/2010 Season Formulation - July 25, 2008 Approval Letter - Influenza Virus Vaccine Live, Intranasal
New Formulation: 2008-2009 Unites States formulation. - July 3, 2008 Approval Letter - Influenza Virus Vaccine Live, Intranasal
Labeling revisions for the 2008-2009 influenza season. - September 19, 2007 Approval Letter - Influenza Virus Vaccine Live, Intranasal
Indication Revision: For the active immunization of individuals 2-49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. - FDA Approves Nasal Influenza Vaccine for Use in Younger Children
Press Release: September 19, 2007 - Nasal Influenza Vaccine Approved for Younger Children
Consumer Article: September 2007 - January 5, 2007 Approval Letter - Influenza Virus Vaccine Live, Intranasal
New Formulation: Convert from the frozen formulation to a liquid formulation. - July 21, 2006 Approval Letter - Influenza Virus Vaccine Live, Intranasal
New Formulation: 2006-2007 United States formulation. - June 15, 2006 Approval Letter - Influenza Virus Vaccine Live, Intranasal
Labeling Change: Labeling revisions for the 2006-2007 influenza season. - August 18, 2005 Approval Letter - Influenza Virus Vaccine Live, Intranasal
New Formulation: 2005-2006 United States formulation. - March 18, 2005 Approval Letter - Influenza Virus Vaccine Live, Intranasal
Labeling Change: Changes to the previously approved 2004-2005 US labeling (package insert). - November 2, 2004 Approval Letter - Influenza Virus Vaccine Live, Intranasal
New Storage Conditions: Storage of FluMist vaccine for the current 2004-2005 influenza vaccination season in a conventional frost-free freezer without a "FreezeBox". - June 17, 2003 Approval Letter - Influenza Virus Vaccine Live, Intranasal
Indication: For active immunization for the prevention of disease caused by influenza A and B viruses in healthy children and adolescents, 5-17 years of age, and healthy adults, 18-49 years of age. - FluMist (Intranasal Influenza Virus Vaccine) Questions and Answers
-
-
-